Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAETM (zuranolone) capsules, for oral use, CIVInitial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
ZURZUVAE is indicated for the treatment of postpartum depression (PPD) in adults.
- generic_name
- zuranolone
- product_names
- zuranolone
- ndc
- 64406-031, 64406-031-01, 64406-030, 64406-030-01, 64406-030-02, 64406-029, 64406-029-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en